Next Generation Sequencing (NGS) market research provides a new perspective into the components and workings on global as well as regional levels. The report serving as an invaluable source of guidance for readers covers an analysis overview of the industry chain of the global market and discusses key elements associated with it, the report focuses on the global status, future forecast, growth opportunity, key market, and key players.
Next Generation Sequencing (NGS) market size was estimated at USD 11.59 billion in 2023 and is projected to reach USD 29.84 billion in 2030 at a CAGR of 14.47% during the forecast period 2023-2030.
Get Free Sample Report@ https://www.delvens.com/get-free-sample/next-generation-sequencing-ngs-market
Next-generation sequencing (NGS) is a massively parallel sequencing method that offers scalability, high throughput, and high speed for genome-wide sequencing of nucleotides. Because it involves the preparation of material for the subsequent sequencing reaction, DNA presequencing is one of the most important processes in a common sequencing protocol.
Globally, NGS is increasingly integrated into clinical laboratory analysis, testing and disease diagnosis in the healthcare industry. In pharmacogenomics, next-generation sequencing (NGS) is often used to accelerate the drug discovery process.
Competitive Landscape:
- 10X Genomics
- Agilent Technologies
- BGI Group
- Bio-Rad Laboratories Inc.
- Brooks Automation Inc.
- CD Genomics
- DNASTAR Inc.
- Eurofins Scientific
- Hoffmann-La Roche Ltd.
- Illumina Inc.
- Macrogen Inc.
- New England Biolabs
- Novogene Corporation Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- Precigen Inc., (Intrexon Bioinformatics Germany GmbH)
- Promega Corporation
- Psomagen
- Qiagen
- Takara Bio
- Tecan Trading Group
- Thermo Fisher Scientific Inc.
- Zymo Research and More
For More Inquiry Contact us@ https://www.delvens.com/Inquire-before-buying/next-generation-sequencing-ngs-market
Next Generation Sequencing (NGS) Market Segmentations:
By Product
- Consumables
- Sample Preparation Consumables
- DNA Fragmentation, End Repair, A-
- Tailing and Size Selection
By Application
- Diagnostics
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications
By Technology
- Sequencing by Synthesis
- lon Semiconductor Sequencing
- Sequencing by Ligation
- Other Technologies
By End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology
- Hospitals and Clinics
- Other End Users
Regional Level Scope
- North America,
- Europe,
- Asia-Pacific,
- South America, and
- Middle East, and Africa
Recent Developments
- In January, 2023, QIAGEN announced a strategic partnership with California-based population genomics leader Helix to advance next-generation sequencing companion diagnostics in hereditary diseases.
- In March, 2023, The company SOPHiA GENETICS announced a new partnership with Qiagen that will pair QIAseq reagent technology with the DDM platform to enhance tumor analysis through next-generation sequencing (NGS).
Access Full Report@ https://www.delvens.com/report/next-generation-sequencing-ngs-market
In addition to the market data for the Next Generation Sequencing (NGS) market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Browse More Reports from Delvens:
Assisted Living (AL) market size was estimated at USD 180.70 billion in 2023 and is projected to reach USD 305.70 billion in 2030 at a CAGR of 7.8% during the forecast period 2023-2030.
Congenital Heart Disease (CHD) market size was estimated at USD 4.47 billion in 2023 and is projected to reach USD 8.11 billion in 2030 at a CAGR of 8.87% during the forecast period 2023-2030.
Periodontal Disease Treatment market size was estimated at USD 799.17 million in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of 8.76% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT Telecom, Chemicals Materials, Semiconductor Electronics, Energy, Pharmaceutical, Consumer Goods Services, Food Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
